(Q44957319)

7 December 2017

title

Breast cancer incidence trends in Norway--explained by hormone therapy or mammographic screening? (English)

1 reference

7 December 2017

1 reference

3

Giske Ursin

1 reference

7 December 2017

1

Solveig Hofvind

1 reference

7 December 2017

Solveig Sakshaug

2

1 reference

7 December 2017

Sidsel Graff-Iversen

series ordinal

4

1 reference

7 December 2017

language of work or name

English

0 references

publication date

22 September 2011

1 reference

International Journal of Cancer

7 December 2017

published in

1 reference

7 December 2017

volume

130

1 reference

7 December 2017

issue

12

1 reference

7 December 2017

page(s)

2930-2938

1 reference

Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives

7 December 2017

cites work

1 reference

The decrease in breast-cancer incidence in 2003 in the United States

21 January 2018

1 reference

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

21 January 2018

1 reference

Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

21 January 2018

1 reference

Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study

21 January 2018

1 reference

Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.

21 January 2018

1 reference

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years

21 January 2018

1 reference

Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva.

21 January 2018

1 reference

Decline in breast cancer incidence in the Flemish region of Belgium after a decline in hormonal replacement therapy

21 January 2018

1 reference

Breast cancer incidence and use of hormone therapy in Denmark 1978-2007.

21 January 2018

1 reference

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 January 2018

1 reference

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

21 January 2018

1 reference

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

21 January 2018

1 reference

Bias in breast cancer analyses due to error in age at menopause.

21 January 2018

1 reference

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 January 2018

1 reference

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

21 January 2018

1 reference

Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?

21 January 2018

1 reference

Hormone replacement therapy regimens and breast cancer risk(1).

21 January 2018

1 reference

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial

21 January 2018

1 reference

Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.

21 January 2018

1 reference

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

21 January 2018

1 reference

Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists.

21 January 2018

1 reference

Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens

21 January 2018

1 reference

An overview of menopausal oestrogen-progestin hormone therapy and breast cancer risk

21 January 2018

1 reference

Sustained lower rates of breast cancer in the United States

21 January 2018

1 reference

Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program

21 January 2018

1 reference

Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness

21 January 2018

1 reference

Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy

21 January 2018

1 reference

The contribution of postmenopausal hormone use cessation to the declining incidence of breast cancer

21 January 2018

1 reference

Declines in breast cancer after the WHI: apparent impact of hormone therapy

21 January 2018

1 reference

Studies comparing screen-film mammography and full-field digital mammography in breast cancer screening: updated review

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.26280

1 reference

7 December 2017

1 reference